MedPath

Eggs as Part of a Healthy Breakfast

Not Applicable
Completed
Conditions
Cardiovascular Diseases
Registration Number
NCT02297464
Lead Sponsor
University of Connecticut
Brief Summary

Contrary to popular belief, previous studies have demonstrated beneficial effects of whole egg consumption in modifying biomarkers indicative of a greater risk of coronary heart disease (CHD), chronic inflammation, and insulin resistance. The following study is designed to conduct a comprehensive evaluation of consuming an egg-based breakfast compared to an oatmeal-based breakfast on lipid biomarkers, oxidative stress, inflammation, insulin sensitivity, and satiety in young, healthy men and women. The investigators hypothesize that the consumption of 2 eggs per day will not negatively impact plasma lipids in a young, healthy population.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
50
Inclusion Criteria
  • BMI 18.5-30, willing to consume eggs and oatmeal daily, proficient in English, and with a healthy lipid profile.
Exclusion Criteria
  • Currently have liver disease, renal disease, diabetes, cancer, history of stroke or heart disease
  • Currently taking glucose lowering drugs or supplements
  • Plasma triglycerides >500 mg/dL, glucose >126, total cholesterol >240
  • Pregnant, lactating, or have endocrine or metabolic disorders
  • BMI ≥ 30
  • Blood pressure > 140/90 (average of 3 readings)
  • Allergies to eggs
  • Celiac disease or gluten sensitivity

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Spectrophotometry, NMR and ELISA will assess plasma lipids.1 year
Secondary Outcome Measures
NameTimeMethod
Visual analog scales (VAS) and ELISA assays will assess satiety.1 year

Trial Locations

Locations (1)

University of Connecticut

🇺🇸

Storrs, Connecticut, United States

University of Connecticut
🇺🇸Storrs, Connecticut, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.